Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Public Library of Science full text link Public Library of Science Free PMC article
Full text links

Actions

.2015 Dec 18;10(12):e0144704.
doi: 10.1371/journal.pone.0144704. eCollection 2015.

Timberol® Inhibits TAAR5-Mediated Responses to Trimethylamine and Influences the Olfactory Threshold in Humans

Affiliations

Timberol® Inhibits TAAR5-Mediated Responses to Trimethylamine and Influences the Olfactory Threshold in Humans

Ivonne Wallrabenstein et al. PLoS One..

Abstract

In mice, trace amine-associated receptors (TAARs) are interspersed in the olfactory epithelium and constitute a chemosensory subsystem that is highly specific for detecting volatile amines. Humans possess six putative functional TAAR genes. Human TAAR5 (hTAAR5) is highly expressed in the olfactory mucosa and was shown to be specifically activated by trimethylamine. In this study, we were challenged to uncover an effective blocker substance for trimethylamine-induced hTAAR5 activation. To monitor blocking effects, we recombinantly expressed hTAAR5 and employed a commonly used Cre-luciferase reporter gene assay. Among all tested potential blocker substances, Timberol®, an amber-woody fragrance, is able to inhibit the trimethylamine-induced hTAAR5 activation up to 96%. Moreover, human psychophysical data showed that the presence of Timberol® increases the olfactory detection threshold for the characteristic fishy odor of trimethylamine by almost one order of magnitude. In conclusion, our results show that among tested receptors Timberol® is a specific and potent antagonist for the hTAAR5-mediated response to trimethylamine in a heterologous system. Furthermore, our data concerning the observed shift of the olfactory detection threshold in vivo implicate that hTAAR5 or other receptors that may be inhibited by Timberol® could be involved in the high affinity olfactory perception of trimethylamine in humans.

PubMed Disclaimer

Conflict of interest statement

Competing Interests:The authors have the following interests: Co-authors Marco Singer and Johannes Panten are employed by Symrise AG. Timberol is a Symrise product. Part of the findings described herein are subject of a pending patent. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials as detailed online in the guide for authors.

Figures

Fig 1
Fig 1. Blocker Screening.
Each of the applied mixtures contained the agonist TMA (300 μM) and a putative antagonistic substance (100 μM). Responses were normalized to the agonist TMA alone. (A) No significant blocking effects of structural TMA analogs (n = 3–6). (B) Significantly stronger blocking effect of Timberol® compared to the other tested substances (n = 3–7). *** p<0.001
Fig 2
Fig 2. Blocker properties of Timberol®.
(A) Concentration-inhibition curve (n = 3). Each response was normalized to the agonist TMA alone. Calculated IC50 for 100 μM TMA on hTAAR5 was 27.8 μM ± 6.5 μM, and the IC50 for 30 μM TMA was 16.6 μM ± 0.9 μM. The curve shift was significant (* p<0.05). (B) Concentration-response curve (n = 3). Each response was normalized to forskolin. Calculated EC50 for TMA on hTAAR5 was 104.8 μM ± 26.02 μM. TMA in the presence of Timberol® (100 μM) revealed an EC50 of 208.4 μM ± 95.10 μM. Curve shift was significant (* p<0.05).
Fig 3
Fig 3. Blocking effect of Timberol® is mediated by hTAAR5.
Timberol® (100 μM) was either applied alone (normalized to unstimulated control) or in a mixture with 10 μM forskolin (normalized to forskolin alone) (n = 3–6). Timberol® did not affect measured luciferase activity (p>0.05).
Fig 4
Fig 4. Blocking effect of Timberol® is exclusively mediated by hTAAR5.
Each response was normalized to corresponding agonist alone. Left: Concentration-response curves (n = 3) of (A) azelaic acid and MOR42-3 and (B) nonanoic acid and hOR51E1. Right: Blocking effects (n = 3) of Timberol® (30 μM) on (A) MOR42-3-mediated responses to azelaic acid and (B) hOR51E-mediated responses to nonanoic acid. No significant blocking effects were observed. Gray bars represent the blocking effect of Timberol® (30 μM) on hTAAR5-mediated responses to TMA in a concentration close to calculated EC50.
Fig 5
Fig 5. (A) Box plots of TMA thresholds. In the presence of Timberol®, the threshold of TMA was shifted to a higher concentration compared to TMA alone or in the presence of Ambrocenide® and Mugetanol.* p<0.05. (B) Scatterplots of individual thresholds with TMA.
Fig 6
Fig 6. (A) Box plots of triethylamine (TEA) thresholds. The addition of Timberol® does not significantly alter the TEA threshold. (B) Scatterplots of individual thresholds with TEA.
See this image and copyright information in PMC

References

    1. Treacy EP, Akerman BR, Chow LML, Youil R, Bibeau C, Lin J, et al. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Human Molecular Genetics. 1998. May;7(5):839–45. - PubMed
    1. Zschocke J, Kohlmueller D, Quak E, Meissner T, Hoffmann GF, Mayatepek E. Mild trimethylaminuria caused by common variants in FMO3 gene. Lancet. 1999. September 4;354(9181):834–5. - PubMed
    1. Mitchell SC, Smith RL. Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos. 2001. April;29(4 Pt 2):517–21. - PubMed
    1. Zhang AQ, Mitchell SC, Smith RL. Exacerbation of symptoms of fish-odour syndrome during menstruation. Lancet. 1996. December 21–28;348(9043):1740–1. - PubMed
    1. Shimizu M, Cashman JR, Yamazaki H. Transient trimethylaminuria related to menstruation. BMC Med Genet. 2007;8:2 - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Full text links
Public Library of Science full text link Public Library of Science Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2026 Movatter.jp